Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)-Reference-Cited by-同舟云学术

Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)

Published:2007-05 Issue:4 Volume:13 Page:230-239
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Arvanitakis Zoe,Witte Robert J.,Dickson Dennis W.,Tsuboi Yoshio,Uitti Ryan J.,Slowinski Jerzy,Hutton Michael L.,Lin Siong-Chi,Boeve Bradley F.,Cheshire William P.,Pooley Robert A.,Liss Julie M.,Caviness John N.,Strongosky Audrey J.,Wszolek Zbigniew K.

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference33 articles.

1. Neurofibrillary pathology of Alzheimer's disease and other tauopathies;Goedert;Prog Brain Res,1998

2. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments;Spillantini;Proc Natl Acad Sci U S A,1997

3. Recent advances in the understanding of tau protein and movement disorders;Arvanitakis;Curr Opin Neurol,2001

4. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model;Zhang;Proc Natl Acad Sci USA,2005

5. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration;Wszolek;Ann Neurol,1992

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders;Progress in Neurobiology;2023-12

2. Molecular imaging biomarkers in familial frontotemporal lobar degeneration: Progress and prospects;Frontiers in Neurology;2022-08-16

3. Frontotemporal Dementia and Glucose Metabolism;Frontiers in Neuroscience;2022-02-23

4. Pallidal degenerations and related disorders: an update;Journal of Neural Transmission;2021-08-07

5. Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers;Alzheimer's Research & Therapy;2021-02-10